RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Clinical Trials Register Information for EU Now Available Through WHO

Clinical Trials Register Information for EU Now Available Through WHO

Posted 27 March 2012 | By Alexander Gaffney, RAC

The European Medicines Agency (EMA) announced this week it is making the EMA-managed EU Clinical Trials Register (EU-CTR) immediately made available and accessible through the World Health Organization's International Clinical Trials Registry Platform (ICTRP), adding a prominent registry to a growing number of international bodies.

"The availability of the register on the WHO ICTRP platform provides wider access to the information contained in the registry and contributes to the dissemination of information related to authorised clinical trials for use by the scientific community and the public," said EMA in a statement.

ICTRP currently includes primary registries from Australia, Brazil, China, Korea, India, Japan and the Netherlands. The inclusion of the EU-CTR adds 17,141 clinical trials to its registry, including 2,252 pediatric trials.

The information is set to be transmitted from EU-CTR to ICTRP once every week.

EMA - EU Clinical Trials Register information now available through WHO's International Clinical Trials Registry Platform

WHO - International Clinical Trials Registry Platform (ICTRP)